# FDA 483 - Centaur Inc - February 01, 2024

Source: https://www.globalkeysolutions.net/records/483/centaur-inc/ad3ae69d-3424-4d98-a687-f45ff54d122f

> FDA 483 for Centaur Inc on February 01, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Centaur Inc
- Inspection Date: 2024-02-01
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West II
- Summary: Centaur Inc. in Olathe, KS, a drug manufacturer, received a Form 483 citing significant quality control deficiencies during an FDA inspection from January 29 to February 1, 2024. The firm failed to thoroughly investigate out-of-specification water system results and lacked proper sampling procedures, impacting the quality assurance of multiple drug product batches.

## Related Officers

- [Consumer Safety Officer, FDA](https://www.globalkeysolutions.net/people/conner-n-mann/626fec03-b389-435c-b038-376fcc0952ac)

Company: https://www.globalkeysolutions.net/companies/centaur-inc/9106eaba-0e13-420b-a044-e6a6a9eb9459

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-ii/8851d151-0390-4d17-be66-fd86d12aa6b8